Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
Jeneng umum: Sars-cov-2 (covid-19) Vaccine, Protein Subunit, Adjuvanted (novavax) (SARS-COV-2 (COVID-19) VAX-een, PROE-teen SUB-u-nit, AD-joo-van-ted (NO-va-vax))
Kelas obat:
Vaksin virus
Panganggone Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
Vaksin SARS-CoV-2 (subunit protein, adjuvant) diselidiki minangka imunisasi aktif nglawan COVID-19 sing disebabake dening virus SARS-CoV-2 ing pasien umur 12 taun utawa luwih. Vaksin SARS-CoV-2 (COVID-19) digunakake kanggo nyegah penyakit koronavirus 2019 (COVID-19) sing disebabake dening sindrom pernapasan akut parah coronavirus 2 (SARS-CoV-2).
Vaksin iki mung diwenehake dening utawa ing pengawasan langsung saka dhokter sampeyan.
Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax) efek sisih
Bebarengan karo efek sing dibutuhake, obat bisa nyebabake efek sing ora dikarepake. Sanajan ora kabeh efek samping kasebut bisa kedadeyan, yen kedadeyan bisa uga mbutuhake perawatan medis.
Enggal takon dhokter utawa perawat yen ana efek samping ing ngisor iki:
Luwih umum
Jarang
Kedadeyan ora dingerteni
Sawetara efek samping bisa kedadeyan sing biasane ora mbutuhake perawatan medis. Efek samping kasebut bisa ilang sajrone perawatan amarga awak nyetel obat kasebut. Uga, profesional perawatan kesehatan sampeyan bisa uga ngandhani babagan cara kanggo nyegah utawa nyuda sawetara efek samping kasebut. Priksa karo profesional perawatan kesehatan yen ana efek samping ing ngisor iki terus utawa ngganggu utawa yen sampeyan duwe pitakon babagan:
Luwih umum
Efek sisih liyane sing ora kadhaptar uga bisa kedadeyan ing sawetara pasien. Yen sampeyan weruh efek liyane, takon karo profesional kesehatan.
Telpon dhokter sampeyan kanggo pitunjuk babagan efek samping. Sampeyan bisa nglaporake efek samping menyang FDA ing 1-800-FDA-1088.
Sadurunge njupuk Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
Nalika mutusake nggunakake obat, risiko njupuk obat kasebut kudu ditimbang karo kabecikan sing bakal ditindakake. Iki minangka keputusan sing bakal ditindakake sampeyan lan dhokter sampeyan. Kanggo obat iki, ing ngisor iki kudu dianggep:
Alergi
Marang dhokter sampeyan yen sampeyan nate ngalami reaksi sing ora biasa utawa alergi kanggo obat iki utawa obat liyane. Uga ngandhani profesional perawatan kesehatan yen sampeyan duwe jinis alergi liyane, kayata panganan, pewarna, pengawet, utawa kewan. Kanggo produk non-resep, waca label utawa bahan paket kasebut kanthi teliti.
Pediatrik
Sinau sing cocog durung ditindakake babagan hubungan umur karo efek vaksin SARS-CoV-2 (COVID-19) ing bocah sing umure luwih enom saka 12 taun. Keamanan lan khasiat durung ditetepake.
Geriatri
Sinau sing cocog sing ditindakake nganti saiki durung nuduhake masalah khusus geriatrik sing bakal mbatesi kegunaan vaksin SARS-CoV-2 (COVID-19) ing wong tuwa.
Interaksi karo Obat
Sanajan obat-obatan tartamtu ora bisa digunakake bebarengan, ing kasus liyane, rong obat beda bisa digunakake bebarengan sanajan ana interaksi. Ing kasus iki, dhokter sampeyan bisa uga pengin ngganti dosis, utawa pancegahan liyane bisa uga perlu. Nalika sampeyan nampa obat iki, penting banget yen profesional kesehatan sampeyan ngerti yen sampeyan nggunakake obat-obatan ing ngisor iki. Interaksi ing ngisor iki wis dipilih adhedhasar potensial pinunjul lan ora mesthi kalebu kabeh.
Nggunakake obat iki karo obat-obatan ing ngisor iki biasane ora dianjurake, nanging bisa uga dibutuhake ing sawetara kasus. Yen loro obat kasebut diwènèhaké bebarengan, dhokter sampeyan bisa ngganti dosis utawa sepira kerepe sampeyan nggunakake siji utawa loro-lorone obat kasebut.
Interaksi karo Pangan/Tembakau/Alkohol
Obat-obatan tartamtu ora kena digunakake ing utawa watara wektu mangan utawa mangan jinis panganan tartamtu amarga interaksi bisa kedadeyan. Nggunakake alkohol utawa rokok karo obat-obatan tartamtu uga bisa nyebabake interaksi. Rembugan karo profesional kesehatan babagan panggunaan obat karo panganan, alkohol, utawa rokok.
Masalah Medis Liyane
Ana masalah medis liyane bisa mengaruhi panggunaan obat iki. Priksa manawa sampeyan ngandhani dhokter yen sampeyan duwe masalah medis liyane, utamane:
Related obat
- Abrysvo
- ACAM2000
- Adenovirus vaccine, live
- Afluria
- Afluria 2015-2016 Formula
- Afluria PF Pediatric Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2022-2023 injection
- Afluria PF Quadrivalent 2023-2024 injection
- Afluria Quadrivalent 2021-2022 injection
- Afluria Quadrivalent 2022-2023 injection
- Afluria Quadrivalent 2023-2024 injection
- Agriflu
- Arexvy
- Attenuvax
- Audenz
- Comirnaty
- Comirnaty (2023-2024) PF (cvx 309) 2023-2024
- COVID-19 (12y+) vaccine Spikevax 2023-2024
- COVID-19 (12y+) vaccine, Pfizer 2023-2024
- COVID-19 (5y-11y) vaccine, Pfizer 2023-2024
- COVID-19 (6m-11y) vaccine, Moderna 2023-2024
- COVID-19 (6m-4y) vaccine, Pfizer 2023-2024
- COVID-19 vaccine, Novavax (2023-2024)
- Mumps virus vaccine, live
- Mumpsvax
- Cervarix
- Dengue tetravalent vaccine, live
- Dengue vaccine
- Dengvaxia
- Dryvax
- Engerix-B
- Engerix-B (HepB)
- Engerix-B Pediatric
- Fluad
- Fluad 2017-2018 Formula
- Fluad Quadrivalent PF 2022-2023 injection
- Fluad Quadrivalent PF 2023-2024 injection
- Fluarix PF Quadrivalent 2021-2022 injection
- Fluarix PF Quadrivalent 2022-2023 injection
- Fluarix PF Quadrivalent 2023-2024 injection
- Fluarix Quadrivalent
- Fluarix Quadrivalent 2013-2014 Formula
- Fluarix Quadrivalent 2015-2016 Formula
- Flublok 2015-2016 Formula
- Flublok 2016-2017 Formula
- Flublok 2017-2018 Formula
- Flublok Quadrivalent
- Flublok Quadrivalent 2016-2017 Formula
- Flublok Quadrivalent 2017-2018 Formula
- Flublok Quadrivalent 2021-2022 injection
- Flublok Quadrivalent 2022-2023 injection
- Flublok Quadrivalent 2023-2024 injection
- Flucelvax 2015-2016 Formula
- Flucelvax PF Quadrivalent 2021-2022 injection
- Flucelvax PF Quadrivalent 2022-2023 injection
- Flucelvax PF Quadrivalent 2023-2024 injection
- Flucelvax Quadrivalent
- Flucelvax Quadrivalent 2021-2022 injection
- Flucelvax Quadrivalent 2022-2023 injection
- Flucelvax Quadrivalent 2023-2024 injection
- FluLaval PF Quadrivalent 2021-2022 injection
- FluLaval PF Quadrivalent 2022-2023 injection
- FluLaval PF Quadrivalent 2023-2024 injection
- Flulaval Quadravalent 2013-2014 Season
- FluLaval Quadrivalent
- FluLaval Quadrivalent 2015-2016 Formula
- Flumist
- FluMist Quadrivalent 2015-2016 Formula
- FluMist Quadrivalent 2023-2024 nasal
- Fluvirin 2015-2016 Formula
- Fluzone 2013-2014 Formula
- Fluzone 2015-2016 Formula
- Fluzone High Dose 2015-2016 Formula
- Fluzone High-Dose Quadrivalent PF 2021-2022 injection
- Fluzone High-Dose Quadrivalent PF 2022-2023 injection
- Fluzone High-Dose Quadrivalent PF 2023-2024 injection
- Fluzone Intradermal Quadrivalent 2014-2015 Formula
- Fluzone Intradermal Quadrivalent 2015-2016 Formula
- Fluzone PF Pediatric Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2022-2023 injection
- Fluzone PF Quadrivalent 2023-2024 injection
- Fluzone Quadrivalent
- Fluzone Quadrivalent 2021-2022 injection
- Fluzone Quadrivalent 2022-2023 injection
- Fluzone Quadrivalent 2023-2024 injection
- Gardasil 9
- Gardasil 9 Vaccine
- Havrix
- Havrix Pediatric
- Hepatitis A adult vaccine
- Hepatitis A pediatric vaccine
- Hepatitis a vaccine
- Hepatitis B adult vaccine
- Hepatitis B pediatric vaccine
- Hepatitis b vaccine
- Hepatitis b vaccine recombinant, adjuvanted
- Heplisav-B
- Human papillomavirus (HPV) vaccine, 9-valent
- Human papillomavirus vaccine
- Imovax Rabies human diploid cell
- Influenza A (H1N1) 2009 Monovalent Vaccine
- Influenza a virus vaccine, h1n1, inactivated
- Influenza a virus vaccine, h5n1, adjuvanted
- Influenza virus vaccine
- Influenza virus vaccine injection
- Influenza virus vaccine nasal
- Influenza virus vaccine recombinant
- Influenza virus vaccine, adjuvanted
- Influenza Virus Vaccine, H5N1
- Influenza virus vaccine, live
- Ipol
- Ixiaro
- Janssen - Johnson & Johnson COVID-19 Vaccine
- Japanese encephalitis virus vaccine SA14-14-2
- Jynneos
- Measles virus vaccine, live
- Meruvax II
- Moderna COVID-19 (2023-2024) PF Vaccine (cvx 311) 2023-2024
- Moderna COVID-19 Vaccine
- Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) 2023-2024
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) 2023-2024
- Pfizer-BioNTech COVID-19 Vaccine
- Polio vaccine, inactivated
- Poliovirus vaccine, inactivated
- PreHevbrio
- RabAvert purified chick embryo cell
- Rabies vaccine human diploid cell
- Rabies vaccine purified chick embryo cell
- Recombivax HB
- Recombivax HB Adult
- Recombivax HB Dialysis Formulation
- Recombivax HB Pediatric/Adolescent
- Respiratory syncytial virus (RSV) vaccine
- Respiratory syncytial virus vaccine
- Respiratory syncytial virus vaccine, adjuvanted
- Rotarix
- Rotateq
- Rotavirus vaccine, live
- Rubella virus vaccine, live
- Sars-cov-2 (covid-19) vaccine, adenovirus 26 vector (janssen)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (moderna)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (pfizer)
- Sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (moderna)
- Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
- Shingrix
- Smallpox and monkeypox vaccine
- Smallpox monkeypox vaccine, live non-replicating
- Smallpox vaccine
- Spikevax
- Spikevax (2023-2024) PF (cvx 312) 2023-2024
- Tick-borne encephalitis pediatric vaccine
- Tick-borne encephalitis vaccine
- TicoVac
- TicoVac Pediatric
- Vaqta
- Vaqta Pediatric
- Varicella virus (chickenpox) vaccine
- Varicella virus vaccine, live
- Varivax
- Yellow fever vaccine
- YF-Vax
- Zostavax
- Zoster vaccine inactivated
- Zoster vaccine recombinant, adjuvanted
- Zoster vaccine, live
Carane nggunakake Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
Perawat utawa profesional kesehatan liyane sing dilatih bakal menehi obat iki ing fasilitas medis. Diwenehake minangka tembakan menyang salah sawijining otot.
Pasien 12 taun lan luwih sing wis nampa vaksin COVID-19: Diwenehake minangka dosis siji paling sethithik 2 sasi sawise nampa dosis pungkasan vaksin COVID-19.
Pasien umur 12 taun lan luwih sing durung nampa vaksin COVID-19: Diwenehake ing 2 dosis kanthi interval 3 minggu.
Pasien umur 12 taun lan luwih sing duwe sistem kekebalan sing lemah: 1 dosis tambahan vaksin Novavax COVID-19, Adjuvant bisa diwenehake paling ora 2 sasi sawise dosis pungkasan vaksin COVID-19. Dokter sampeyan bisa menehi dosis tambahan gumantung saka kondisi sampeyan.
Vaksin iki dilengkapi Lembar Fakta kanggo Panampa lan Pengasuh. Waca lan tututi informasi ing Lembar Fakta kasebut kanthi teliti. Takon dhokter yen sampeyan duwe pitakon.
Pènget
Pesthekake kanggo menehi kabar marang dhokter sampeyan babagan efek samping (contone, krasa semaput) sing kedadeyan sawise sampeyan nampa vaksin iki.
Semaput bisa kedadeyan sawise sampeyan nampa vaksin iki. Dokter sampeyan pengin sampeyan diamati sawise sampeyan entuk injeksi kanggo nyegah lan ngatur pingsan.
Vaksin iki bisa nyebabake reaksi alergi sing serius, kalebu anafilaksis, sing bisa ngancam nyawa lan mbutuhake perhatian medis langsung. Marang dhokter sampeyan langsung yen sampeyan duwe ruam, gatel, deg-degan cepet, alangan ambegan, alangan ngulu, utawa abuh ing tangan, pasuryan, utawa tutuk sawise nampa vaksin.
Vaksin iki bisa nambah risiko masalah jantung sing serius (contone, miokarditis, perikarditis), utamane sawise sampeyan nampa dosis kaping pindho. Priksa langsung karo dhokter yen sampeyan duwe kuatir, kulit biru utawa pucet, nyeri dada, bisa uga pindhah menyang lengen kiwa, gulu, utawa pundhak, mriyang, ndredheg, detak jantung sing cepet, alangan ambegan, utawa lemes utawa kelemahan sing ora biasa.
Vaksin iki bisa uga ora nglindhungi saben wong sing nampa. Vaksin iki ora bakal nambani gejala infeksi COVID-19 yen sampeyan wis nandhang penyakit kasebut. Penting banget yen sampeyan njupuk pancegahan kanggo nyuda risiko COVID-19.
Aja njupuk obat liya kajaba wis dirembug karo dhokter. Iki kalebu obat-obatan resep utawa non-resep (over-the-counter [OTC]) lan suplemen herbal utawa vitamin.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions